In addition, we observed that treatment with scaffolded SRF231 in primary CLL cells or Ri-1 lymphoma cells did not induce caspase 3 cleavage as compared to the positive control venetoclax (Suppl. The gene discussed is CASP3; the disease is lymphoma.